PHILADELPHIA--(BUSINESS WIRE)--Exegenesis Bio, a rapidly growing global genetic medicines company, is pleased to announce the presentation of clinical efficacy and safety data from its EXG001-307 ...
Hip instability is prevalent across all types of spinal muscular atrophy (SMA), although it occurs most rapidly in SMA type 1, according to a new study abstract appearing in Developmental Medicine & ...
According to researchers, the most prevalent risk factors in children with type 1 spinal muscular atrophy (SMA) are hypercalciuria and elevated urine specific gravity. Children with spinal muscular ...
Children with spinal muscular atrophy (SMA), a rare autosomal recessive disease that results in progressive muscle weakness and atrophy, can suffer the concerning consequences of dysphagia, which ...
Zacks Investment Research on MSN
SmartStop (SMA) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
SmartStop (SMA) reported $70.43 million in revenue for the quarter ended September 2025, representing no change year over year. EPS of $0.47 for the same period compares to $0 a year ago. The reported ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback